{
  "docId": "019dd923-5fed-74f2-a96e-95e01e2140db",
  "docSlug": "bi-c29ebb9687e0a35c",
  "documentTitle": "Flagship biotech Cellarity pitch deck for $121 million Series C round",
  "authorId": "Pitchdecks",
  "authorName": "Cellarity",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.782,
  "pageNumber": 6,
  "pageCount": 12,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "traction",
  "function": "show_traction",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": "The slide uses a combination of line charts, scatter plots, and microscopy images to validate therapeutic potential.",
  "elementsJson": [
    "action_title",
    "line_chart",
    "scatter_plot",
    "photo",
    "callout_box"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fed-74f2-a96e-95e01e2140db/6",
  "deckHref": "/decks/019dd923-5fed-74f2-a96e-95e01e2140db",
  "deckJsonHref": "/decks/019dd923-5fed-74f2-a96e-95e01e2140db.json",
  "deckAnchorHref": "/decks/019dd923-5fed-74f2-a96e-95e01e2140db#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.38,
        "y": 0.725
      },
      "kind": "callout",
      "text": "Treating sickle cell disease with a small molecule comparable to genetic therapy",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3576a05b-dd23-4592-a389-8d7be73e5de4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.71,
        "y": 0.725
      },
      "kind": "callout",
      "text": "Preventing lung cell damage during acute inflammation",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a662d327-d8c5-4c4d-9a81-e716d3f22c90",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.06,
        "y": 0.725
      },
      "kind": "callout",
      "text": "Insulin sensitizing distinct from the PPAR-γ pathway",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ee782043-3382-4a99-b7a6-f6ebd5d5dd78",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "Insulin sensitizing distinct from the PPAR-γ pathway; Treating sickle cell disease with a small molecule comparable to genetic therapy; Preventing lung cell damage during acute inflammation",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-c5b4-748e-9609-0b4ed25e40ef",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.25,
        "x": 0.11,
        "y": 0.245
      },
      "kind": "chart",
      "text": "HbA1c",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9b9992e2-2572-490e-8b6c-8ce0efb10a92",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.25,
        "x": 0.38,
        "y": 0.245
      },
      "kind": "chart",
      "text": "Fold Increase in Red Cells Expressing HbF",
      "attrs": null,
      "subkind": "scatter",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1ad21306-394b-4abe-8018-a188c77518f7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.25,
        "x": 0.71,
        "y": 0.245
      },
      "kind": "image",
      "text": "AB/PAS Staining (Mucus)",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ce732da6-3fbb-4579-87b7-bf55912181ed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "CELLARITY'S PLATFORM ALREADY DELIVERED MULTIPLE GAME CHANGING OPPORTUNITIES",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a480aa73-1853-4e1e-8ff0-cb696662df1c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Storytelling: audience calibration",
      "slug": "audience",
      "agent": "storyteller",
      "layer": "slide",
      "matchId": "dfa5a812-d667-46e5-871b-cdebc8cafedb",
      "evidence": "callout/primary: Treating sickle cell disease with a small molecule comparable to genetic therapy",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 9,
      "from": 6,
      "beatId": "f2442280-52d9-40bc-b7ef-ed2a7514f9f9",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Slides 6-9 present Cellarity's platform and its capabilities",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "7d5b0df4-1b85-4877-af95-be8dacda927c",
      "evidence": "Slides 4-9 imply the consequences of not changing the current approach",
      "position": 0,
      "objective": "What if we don't adopt a new approach?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 12,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "c00672dd-6945-4b60-95d7-ff1c9f632131",
      "evidence": "Slides 3-12 present the 'why' behind Cellarity's mission and vision",
      "position": 1,
      "objective": "Why is Cellarity's approach necessary?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}